Diligence memo · auto-generated · as of July 2, 2026

Avenu Medical, Inc.

Avenu Medical, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Avenu Medical, Inc. operates in Healthtech, based in SAN JUAN CAPISTRANO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Avenu Medical, Inc. has raised $37M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $13M on 2017-02-15.

Most recent recorded round closed around 2018-10-31.

Valuation (modeled)modeled

Provath models Avenu Medical, Inc. at approximately $271M (range $15M–$1.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.03× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 20 months.

Last raise 7.7 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 88% of Healthtech peers (2138 compared).

Modeled value ranks above 89% of those peers.

Closest niche peers: Prenexus Health, LLC, HealthMyne, Inc., Companion Medical, Inc., Health at Scale Corp, Motus GI Medical Technologies, Ltd..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.